Clostridium Difficile clinical trials

Explore recruiting clostridium difficile clinical trials.

Recruiting clostridium difficile studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clostridium Difficile trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a randomized double-blind placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

(SPARROW) Standard versus Pre-emptive Antibiotic Treatment to Reduce the Rate of Infectious Outcomes after Whipple’s procedure (SPARROW): a multicenter, randomized controlled trial

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

Stop of proton-pump inhibitor treatment in patients with liver cirrhosis – a doubleblind, placebo-controlled trial (STOPPIT)

Germany

Phase III and phase IV (Integrated) EU CTIS Study details

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit. Multicentric non-inferiority randomised controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

PipEracillin Tazobactam versus mERoPENem for treatment of bloodstream infections caused by cephalosporin-resistant Enterobacteriaceae - a non-inferiority randomized controlled trial (PETERPEN)

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Clostridium Difficile trials by city

Clostridium Difficile in Toronto Clostridium Difficile in Vancouver Clostridium Difficile in Montreal Clostridium Difficile in Calgary Clostridium Difficile in Edmonton Clostridium Difficile in Ottawa Clostridium Difficile in Winnipeg Clostridium Difficile in Quebec City Clostridium Difficile in Hamilton Clostridium Difficile in Kitchener Clostridium Difficile in London Clostridium Difficile in Halifax Clostridium Difficile in New York Clostridium Difficile in Los Angeles Clostridium Difficile in Chicago Clostridium Difficile in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease